NMT2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.829600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.381420E-01
Normal-vs-Stage2
5.922400E-02
Normal-vs-Stage3
1.457720E-02
Normal-vs-Stage4
5.985200E-01
Stage1-vs-Stage2
8.470000E-01
Stage1-vs-Stage3
5.893400E-01
Stage1-vs-Stage4
3.518600E-01
Stage2-vs-Stage3
3.926600E-01
Stage2-vs-Stage4
1.907850E-01
Stage3-vs-Stage4
1.569780E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.585900E-02
Normal-vs-AfricanAmerican
3.059000E-01
Normal-vs-Asian
1.139760E-01
Caucasian-vs-AfricanAmerican
2.312200E-01
Caucasian-vs-Asian
8.451600E-01
AfricanAmerican-vs-Asian
4.160000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.873600E-02
Normal-vs-Female
8.935600E-02
Male-vs-Female
2.531600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.722000E-01
Normal-vs-Age(41-60Yrs)
1.558450E-01
Normal-vs-Age(61-80Yrs)
2.715700E-02
Normal-vs-Age(81-100Yrs)
5.135500E-03
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.214600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
4.177800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.797600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.421580E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.049600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.229200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.301550E-01
Normal-vs-Daily Drinker
3.052100E-02
Normal-vs-Weekly Drinker
1.140570E-01
Normal-vs-Occasional Drinker
4.839700E-02
Normal-vs-Social Drinker
4.231900E-02
Non Drinker-vs-Daily Drinker
4.820600E-01
Non Drinker-vs-Weekly Drinker
9.208200E-01
Non Drinker-vs-Occasional Drinker
9.114000E-01
Non Drinker-vs-Social Drinker
5.448200E-01
Daily Drinker-vs-Weekly Drinker
6.066800E-01
Daily Drinker-vs-Occasional Drinker
5.381400E-01
Daily Drinker-vs-Social Drinker
9.981400E-01
Weekly Drinker-vs-Occasional Drinker
9.965600E-01
Weekly Drinker-vs-Social Drinker
6.478800E-01
Occasional Drinker-vs-Social Drinker
5.811400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.381410E-01
Normal-vs-Grade 2
3.141700E-02
Normal-vs-Grade 3
6.986100E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.442400E-02
Grade 1-vs-Grade 3
2.813200E-01
Grade 1-vs-Grade 4
1.381410E-01
Grade 2-vs-Grade 3
5.537800E-01
Grade 2-vs-Grade 4
3.141700E-02
Grade 3-vs-Grade 4
6.986100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.866300E-02
Normal-vs-NonDiabetic
5.217500E-02
Diabetic-vs-NonDiabetic
5.403000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.046300E-02
Normal-vs-NoPancreatitis
5.234400E-02
Pancreatitis-vs-NoPancreatitis
8.094400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.980330E-02
Normal-vs-N1
7.490000E-02
N0-vs-N1
2.023400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.529900E-02
Normal-vs-TP53-NonMutant
3.673800E-02
TP53-Mutant-vs-TP53-NonMutant
9.853000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
